Revolution Current Ratio from 2010 to 2024

RVMDW Stock   0.32  0.08  20.00%   
Revolution Medicines, Current Ratio yearly trend continues to be fairly stable with very little volatility. Current Ratio will likely drop to 8.11 in 2024. Current Ratio is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. View All Fundamentals
 
Current Ratio  
First Reported
2010-12-31
Previous Quarter
13.06408019
Current Value
8.11
Quarterly Volatility
7.9634928
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Revolution Medicines, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revolution Medicines,'s main balance sheet or income statement drivers, such as Net Interest Income of 49.5 M, Interest Income of 49.9 M or Interest Expense of 287.9 K, as well as many indicators such as Price To Sales Ratio of 294, Dividend Yield of 0.0 or PTB Ratio of 1.69. Revolution financial statements analysis is a perfect complement when working with Revolution Medicines, Valuation or Volatility modules.
  
Check out the analysis of Revolution Medicines, Correlation against competitors.

Latest Revolution Medicines,'s Current Ratio Growth Pattern

Below is the plot of the Current Ratio of Revolution Medicines, Warrant over the last few years. It is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. Revolution Medicines,'s Current Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Revolution Medicines,'s overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.00 X10 Years Trend
Slightly volatile
   Current Ratio   
       Timeline  

Revolution Current Ratio Regression Statistics

Arithmetic Mean5.85
Geometric Mean3.03
Coefficient Of Variation136.08
Mean Deviation5.69
Median1.24
Standard Deviation7.96
Sample Variance63.42
Range29.2394
R-Value0.63
Mean Square Error41.30
R-Squared0.40
Significance0.01
Slope1.12
Total Sum of Squares887.84

Revolution Current Ratio History

2024 8.11
2023 13.06
2022 10.65
2021 30.48
2020 9.63
2019 3.11
2018 2.8

About Revolution Medicines, Financial Statements

Revolution Medicines, investors use historical fundamental indicators, such as Revolution Medicines,'s Current Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revolution Medicines,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Ratio 13.06  8.11 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revolution Stock Analysis

When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.